Ruben R. Munoz

Ruben R. Munoz

Auto-generated profile, based on publicly available information

Ruben R. Munoz


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KSKevin Sullivan
Kevin Sullivan
HLHaiqing Li
Haiqing Li
AYANNIE YANG
ANNIE YANG
ZZZhifang Zhang
Zhifang Zhang
RMRuben R. Munoz
Ruben R. Munoz
YWYanghee Woo
Yanghee Woo
A spectrum of immune states resulting from tumor resident macrophages and T-lymphocytes in the solid tumor microenvironment correlates with patient outcomes. We hypothesized that in gastric cancer (GC), macrophages in a polarized immunosuppressive transcriptional state would be prognostic of poor survival. We derived transcriptomic signatures for M2 (M2TS, MRC1; MS4A4A; CD36; CCL13; CCL18; CCL23; SLC38A6; FGL2; FN1; MAF) and M1 (M1TS, CCR7; IL2RA; CXCL11; CCL19; CXCL10; PLA1A; PTX3) macrophages, and cytolytic T-lymphocytes (CTLTS, GZMA; GZMB; GZMH; GZMM; PRF1). Primary GC in a TCGA stomach cancer dataset was evaluated for signature expressions, and a log-rank test determined overall survival (OS) and the disease-free interval (DFI). In 341 TCGA GC entries, high M2TS expression was associated with histological types and later stages. Low M2TS expression was associated with significantly better 5-year OS and DFI. We validated M2TS in prospectively collected peritoneal fluid of a GC patient cohort (n = 28). Single-cell RNA sequencing was used for signature expression in CD68+CD163+ cells and the log-rank test compared OS. GC patients with high M2TS in CD68+CD163+ cells in their peritoneal fluid had significantly worse OS than those with low expression. Multivariate analyses confirmed M2TS was significantly and independently associated with survival. As an independent predictor of poor survival, M2TS may be prognostic in primary tumors and peritoneal fluid of GC patients.

2 June 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
NMNicholas Magann
Nicholas Magann
GBGriffin Barnes
Griffin Barnes
RSRyan Schioldager
Ryan Schioldager
FHFabian Hörmann
Fabian Hörmann
RMRubén Muñoz
Rubén Muñoz
CVChristopher Vanderwal
Christopher Vanderwal
The marine alkaloid aleutianamine was reported to have potent and selective activity against the PANC-1 pancreatic cancer cell line, and this exciting activity and its novel structure inspired the development of three exceptional recent syntheses. Our efforts toward an efficient, bioinspired, “Kita-style” synthesis were met with challenges until we adopted the presumably biomimetic rearrangement of dihydrodiscorhabdin B discovered by Tokuyama and co-workers. With our previously reported, scalable synthesis of the tricyclic pyrroloiminoquinone (PIQ) core and the development of a brominated and sulfenylated tyramine reaction partner, a convergent condensation set up for a modified Tokuyama endgame. The early incorporation of the bromine atom increased convergence and obviated a troublesome late-stage halogenation; further, the oxidative thioami-nal formation was dramatically improved, leading to discorhabdin B in only eight steps in the longest linear sequence (LLS) and in hundred milligram quantities. Another notable feature of this work is that no pyrrole N-protecting group was used throughout the sequence. Conversion to aleutianamine without N-protection was not so efficient, but delivered the target in only 10 steps LLS; alternatively, N-tosylation permitted higher yielding rearrangement, per Tokuyama. In this manner, we were able to make hundreds of milligrams of aleutianamine, permitting evaluation of its activity against the NCI 60-cell panel (plus 6 additional pancreatic cancer cell lines), wherein it showed potent activity against several pancreatic and leuke-mia cell lines. In addition, aleutianamine, N-Ts aleutianamine, desbromoaleutianamine, discorhabdin B, and the simpler PIQ makaluvamine J were evaluated against three pancreatic cancer cell lines, and each compound showed sub-micromolar activi-ty in all cases. Critically, the readily available discorhabdin B was the most potent, thus showing that aleutianamine is not special with regard to anti-pancreatic-cancer activity. Finally, the activity of the two aleutianamine analogues yields some potential insight into mechanism of action and offers design principles for chemical probes for target identification.